AU4789099A - Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents - Google Patents

Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents

Info

Publication number
AU4789099A
AU4789099A AU47890/99A AU4789099A AU4789099A AU 4789099 A AU4789099 A AU 4789099A AU 47890/99 A AU47890/99 A AU 47890/99A AU 4789099 A AU4789099 A AU 4789099A AU 4789099 A AU4789099 A AU 4789099A
Authority
AU
Australia
Prior art keywords
tumours
flavonoids
treatment
therapeutic composition
cytotoxic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47890/99A
Other languages
English (en)
Inventor
Francis Darro
Armand Frydman
Robert Kiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Publication of AU4789099A publication Critical patent/AU4789099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
AU47890/99A 1998-07-15 1999-07-13 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents Abandoned AU4789099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9809058A FR2781153B1 (fr) 1998-07-15 1998-07-15 Composition therapeutique a base de flavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
FR9809058 1998-07-15
PCT/FR1999/001714 WO2000003706A1 (fr) 1998-07-15 1999-07-13 Composition therapeutique a base de flavonoïdes destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques

Publications (1)

Publication Number Publication Date
AU4789099A true AU4789099A (en) 2000-02-07

Family

ID=9528648

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47890/99A Abandoned AU4789099A (en) 1998-07-15 1999-07-13 Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents

Country Status (12)

Country Link
EP (1) EP1096930A1 (fr)
JP (1) JP2002520356A (fr)
KR (1) KR20020003349A (fr)
CN (1) CN1139384C (fr)
AU (1) AU4789099A (fr)
BR (1) BR9912816A (fr)
CA (1) CA2337179A1 (fr)
EA (1) EA200100140A1 (fr)
FR (1) FR2781153B1 (fr)
IL (1) IL140588A0 (fr)
WO (1) WO2000003706A1 (fr)
ZA (1) ZA200100239B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002069949A2 (fr) * 2001-03-06 2002-09-12 Prendergast Patrick T Polytherapie pour la reduction de la toxicite d'agents chimiotherapeutiques
EP1808172A3 (fr) * 2002-03-06 2010-05-26 Activephyto Technologies Limited Compostions à base d'extraits botaniques et procédés d'utilisation
AU2003217982A1 (en) * 2002-03-06 2003-09-22 The Medical Research And Education Trust Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol
US20030229136A1 (en) 2002-04-18 2003-12-11 Nurulain Zaveri Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
CN1679539A (zh) * 2005-01-20 2005-10-12 吴一心 抗肿瘤的协同药物组合物
CA2600797A1 (fr) * 2005-03-11 2006-09-21 The Regents Of The University Of Michigan Inhibiteurs de chromen-4-one des elements anti-apoptotiques de la famille bcl-2 et utilisations
GB0808974D0 (en) * 2008-05-16 2008-06-25 Veritron Ltd Plant extract and its therapeutic use
US9808477B2 (en) * 2015-07-29 2017-11-07 Macau University Of Science And Technology Use of nobiletin in cancer treatment
US9808439B2 (en) * 2015-07-29 2017-11-07 Macau University Of Science And Technology Use of tangeretin in cancer treatment
JP6775226B2 (ja) * 2016-06-30 2020-10-28 国立大学法人広島大学 抗癌剤作用増強物質およびそれを備えた抗癌剤キット
CN106562954A (zh) * 2016-11-11 2017-04-19 黄冈师范学院 (去甲基)多甲氧基黄酮联合紫杉醇类药物在制备治疗非小细胞肺癌的药物上的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0617304B2 (ja) * 1982-09-09 1994-03-09 理化学研究所 制癌剤
JPS5959627A (ja) * 1982-09-27 1984-04-05 Tatsuo Miyoshi 制癌剤
JPS60199817A (ja) * 1984-03-23 1985-10-09 Rikagaku Kenkyusho 制癌剤
JPS632925A (ja) * 1986-06-23 1988-01-07 Nippon Kayaku Co Ltd Ｃキナ−ゼ阻害剤および抗腫瘍剤
FR2633182B1 (fr) * 1988-06-23 1993-07-23 Beljanski Mirko Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention
JPH04103532A (ja) * 1990-08-24 1992-04-06 Tatsuo Miyoshi 制癌剤
JPH04103529A (ja) * 1990-08-24 1992-04-06 Tatsuo Miyoshi 制癌剤
JP2514500B2 (ja) * 1991-09-14 1996-07-10 呉羽化学工業株式会社 多剤耐性抑制剤及び発現阻害剤
EP0642793A4 (en) * 1992-05-11 1995-03-29 Tsumura & Co. Apoptosis inducer.
WO1996031206A2 (fr) * 1995-04-07 1996-10-10 Warner-Lambert Company Flavones et coumarines utilisees en tant qu'agents dans le traitement de l'atherosclerose
DE29719198U1 (de) * 1997-10-29 1998-04-23 Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke, 14558 Bergholz-Rehbrücke Flavono/Flavonoid-Zubereitung

Also Published As

Publication number Publication date
JP2002520356A (ja) 2002-07-09
CN1139384C (zh) 2004-02-25
EA200100140A1 (ru) 2001-06-25
FR2781153B1 (fr) 2001-08-03
ZA200100239B (en) 2002-01-09
IL140588A0 (en) 2002-02-10
KR20020003349A (ko) 2002-01-12
CN1313765A (zh) 2001-09-19
CA2337179A1 (fr) 2000-01-27
WO2000003706A1 (fr) 2000-01-27
EP1096930A1 (fr) 2001-05-09
BR9912816A (pt) 2001-05-08
FR2781153A1 (fr) 2000-01-21

Similar Documents

Publication Publication Date Title
HK1105580A1 (en) Use of isoflavone compounds in the manufacture of medicament and composition comprising the same
ATE312642T1 (de) Gelförmiger körperschutzartikel mit therapeutischen zutaten
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
HK1033278A1 (en) Pharmaceutical preparation for use in anti-asthma therapy.
AU5835098A (en) Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures
GB2314022B (en) Blending medical composition with sustained medicament releasability and process for preparing the same
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
HUP0102585A3 (en) Thienylazolylalcoxyethanamin derivatives preparation the same and their use as medicaments
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
HK1020259A1 (en) Composition for use in the treatment and prevention of hyperuricemia.
HUP9904367A3 (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
AU4789099A (en) Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents
AU2837301A (en) Use of polymeric material in the treatment of hard surfaces
HK1001286A1 (en) Benzopyrans and their use as therapeutic agents.
AU5056099A (en) Compounds for use in the treatment of inflammation
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
IL140580A0 (en) Isoflavonoid-based therapeutic composition intended to be used in the treatment of tumours with cytotoxic agents
AU2002226060A1 (en) Compositions containing gangliosides for use in the treatment of skin disorders
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
AU3061199A (en) Skin treatment compositions and the use thereof
AU2002218977A1 (en) Novel marker for the diagnosis and therapy of tumours
GB9904252D0 (en) Composition for the treatment of pain
AU6091299A (en) Treatment device, treatment bed to be used therein and the use thereof
AU2001292500A1 (en) 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted